The project is set to attract significant manufacturing investments of approximately Rs. 10,500 crore and is also projected to create around 1 lakh direct and indirect jobs
Menkes disease is a rare X-linked recessive pediatric disease caused by gene mutations of the copper transporter ATP7A
Parents, teachers, and caregivers play a vital role in spotting early signs of schizophrenia
Attruby is the first and only approved product with a label specifying near-complete stabilization of TTR
The new facility significantly increases Siegfried’s R&D capacity to drive development excellence and further growth
The MoU signed in 2022 has progressed and culminated in the subsumption of FOGSI-led Manyata initiative’s 20 quality standards across NABH’s Certification programs
Commercial license to Synaffix technologies follows a series of successful initial preclinical proof of concept studies
Union Government will provide a health cover of Rs. 5 lakh to any elderly person above 70 years of age
Extension of long-term collaboration includes construction of new customer-dedicated bioconjugation capacity in Visp (CH) and commercial antibody supply of a new ADC
WCK 6777 is the only once-a-day drug in global antibiotic pipeline designed for outpatient parenteral antimicrobial therapy
Subscribe To Our Newsletter & Stay Updated
